iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
80.91%
Change (1 year)
Categories
iBio (IBIO) - Cash on Hand
Cash on Hand as of December 2023 : $2.78 M
According to iBio's latest financial reports the company has $2.78 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
iBio - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $4.3 M | -87.17% |
| 2022-06-30 | $33.52 M | -65.43% |
| 2021-06-30 | $96.97 M | 75.96% |
| 2020-06-30 | $55.11 M | 1146.6% |
| 2019-06-30 | $4.42 M | -72.25% |
| 2018-06-30 | $15.93 M | 97.01% |
| 2017-06-30 | $8.08 M | -64.86% |
| 2016-06-30 | $23.01 M | 142.41% |
| 2015-06-30 | $9.49 M | 164.46% |
| 2014-06-30 | $3.59 M | -18.67% |
| 2013-06-30 | $4.41 M | -21.51% |
| 2012-06-30 | $5.62 M | 97.8% |
| 2011-06-30 | $2.84 M | 212.47% |
| 2010-06-30 | $0.9 M | -12.44% |
| 2009-06-30 | $1.03 M | 5368.27% |
| 2008-06-30 | $0.01 M | 0.89% |
| 2007-06-30 | $0.01 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 822,245.77% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $20.13 M | 622.27% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.30 B | 10,790.10% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.11 B | 3,906.46% | 🇺🇸 USA |